Switch theme
Sign up to access all valuation multiples
JETEMA Co Ltd is a bio venture company. It offers products such as Botulinum toxin, Filler, Anti-aging solutions. The company also offers medical devices and cosmetics.
2009
n/a
LTM Revenue $49.1M
LTM EBITDA $13.3M
$260M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
JETEMA Co. has a last 12-month revenue (LTM) of $49.1M and a last 12-month EBITDA of $13.3M.
In the most recent fiscal year, JETEMA Co. achieved revenue of $50.7M and an EBITDA of $11.5M.
JETEMA Co. expects next 12-month revenue of XXX and NTM EBITDA of XXX
See JETEMA Co. valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $49.1M | XXX | $50.7M | XXX | XXX | XXX |
| Gross Profit | $25.5M | XXX | $24.7M | XXX | XXX | XXX |
| Gross Margin | 52% | XXX | 49% | XXX | XXX | XXX |
| EBITDA | $13.3M | XXX | $11.5M | XXX | XXX | XXX |
| EBITDA Margin | 27% | XXX | 23% | XXX | XXX | XXX |
| EBIT | $7.2M | XXX | $3.0M | XXX | XXX | XXX |
| EBIT Margin | 15% | XXX | 6% | XXX | XXX | XXX |
| Net Profit | $0.3M | XXX | -$0.1M | XXX | XXX | XXX |
| Net Margin | 1% | XXX | 0% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $70.0M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 2, 2025, JETEMA Co.'s stock price is KRW 6960 (or $5).
JETEMA Co. has current market cap of KRW 249B (or $185M), and EV of KRW 351B (or $260M).
See JETEMA Co. trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $260M | $185M | XXX | XXX | XXX | XXX | $-0.01 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 2, 2025, JETEMA Co. has market cap of $185M and EV of $260M.
JETEMA Co.'s trades at 5.1x EV/Revenue multiple, and 22.7x EV/EBITDA.
Equity research analysts estimate JETEMA Co.'s 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
JETEMA Co. has a P/E ratio of 561.1x.
See valuation multiples for JETEMA Co. and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $185M | XXX | $185M | XXX | XXX | XXX |
| EV (current) | $260M | XXX | $260M | XXX | XXX | XXX |
| EV/Revenue | 5.3x | XXX | 5.1x | XXX | XXX | XXX |
| EV/EBITDA | 19.5x | XXX | 22.7x | XXX | XXX | XXX |
| EV/EBIT | 36.2x | XXX | 85.4x | XXX | XXX | XXX |
| EV/Gross Profit | 10.2x | XXX | n/a | XXX | XXX | XXX |
| P/E | 561.1x | XXX | -1325.2x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -69.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialJETEMA Co.'s last 12 month revenue growth is 15%
JETEMA Co.'s revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
JETEMA Co.'s rule of 40 is 53% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
JETEMA Co.'s rule of X is 66% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for JETEMA Co. and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 15% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Margin | 27% | XXX | 23% | XXX | XXX | XXX |
| EBITDA Growth | 20% | XXX | -10% | XXX | XXX | XXX |
| Rule of 40 | 53% | XXX | 38% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 66% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 9% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 14% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 43% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
JETEMA Co. acquired XXX companies to date.
Last acquisition by JETEMA Co. was XXXXXXXX, XXXXX XXXXX XXXXXX . JETEMA Co. acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was JETEMA Co. founded? | JETEMA Co. was founded in 2009. |
| Where is JETEMA Co. headquartered? | JETEMA Co. is headquartered in South Korea. |
| Is JETEMA Co. publicy listed? | Yes, JETEMA Co. is a public company listed on KRX. |
| What is the stock symbol of JETEMA Co.? | JETEMA Co. trades under 216080 ticker. |
| When did JETEMA Co. go public? | JETEMA Co. went public in 2019. |
| Who are competitors of JETEMA Co.? | Similar companies to JETEMA Co. include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of JETEMA Co.? | JETEMA Co.'s current market cap is $185M |
| What is the current revenue of JETEMA Co.? | JETEMA Co.'s last 12 months revenue is $49.1M. |
| What is the current revenue growth of JETEMA Co.? | JETEMA Co. revenue growth (NTM/LTM) is 15%. |
| What is the current EV/Revenue multiple of JETEMA Co.? | Current revenue multiple of JETEMA Co. is 5.3x. |
| Is JETEMA Co. profitable? | Yes, JETEMA Co. is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of JETEMA Co.? | JETEMA Co.'s last 12 months EBITDA is $13.3M. |
| What is JETEMA Co.'s EBITDA margin? | JETEMA Co.'s last 12 months EBITDA margin is 27%. |
| What is the current EV/EBITDA multiple of JETEMA Co.? | Current EBITDA multiple of JETEMA Co. is 19.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
